title: Hypovolaemic shock triggered by P. vivax infection in a patient with mild haemophilia A.
authors.forename: S C P
authors.initials: SC
authors.lastname: Fragoso
authors.forename: M A A
authors.initials: MA
authors.lastname: Alexandre
authors.forename: P J T
authors.initials: PJ
authors.lastname: Santos
authors.forename: M P G
authors.initials: MP
authors.lastname: Mourão
authors.forename: L N M
authors.initials: LN
authors.lastname: Passos
authors.forename: B M L
authors.initials: BM
authors.lastname: Magalhães
authors.forename: A M
authors.initials: AM
authors.lastname: Siqueira
authors.forename: M V G
authors.initials: MV
authors.lastname: Lacerda
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use; D017707:Erythrocyte Transfusion; D005169:Factor VIII / Q000008:administration & dosage*; D006467:Hemophilia A / Q000188:drug therapy / Q000469:parasitology*; D006801:Humans; D016780:Malaria, Vivax / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010966:Plasmodium vivax / Q000302:isolation & purification / Q000378:metabolism; D012769:Shock / Q000209:etiology* / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D000962:Antimalarials; D005169:Factor VIII